TipRanks
Eton Pharmaceuticals Inc (ETON)
NASDAQ:ETON
US Market
ETON
Eton Pharmaceuticals
RESEARCH TOOLSreports
Want to see ETON full AI Analyst Report?

Eton Pharmaceuticals (ETON) Ratios

585 Followers

Eton Pharmaceuticals Ratios

ETON's free cash flow for Q2 2026 was $0.68. For the 2026 fiscal year, ETON's free cash flow was decreased by $ and operating cash flow was $0.34. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.52 1.57 2.06 1.65 3.10
Quick Ratio
 1.30 1.17 1.29 1.60 3.01
Cash Ratio
 0.59 0.67 0.75 1.32 2.52
Solvency Ratio
 0.23 >-0.01 -0.05 >-0.01 -0.61
Operating Cash Flow Ratio
 0.34 0.27 0.05 0.42 0.75
Short-Term Operating Cash Flow Coverage
 1.72 1.20 12.75 1.27 4.67
Net Current Asset Value
$ -623.00K$ -5.38M$ -10.67M$ 10.58M$ 8.05M
Leverage Ratios
Debt-to-Assets Ratio
 0.25 0.34 0.39 0.17 0.26
Debt-to-Equity Ratio
 0.62 1.19 1.23 0.35 0.50
Debt-to-Capital Ratio
 0.38 0.54 0.55 0.26 0.33
Long-Term Debt-to-Capital Ratio
 0.29 0.45 0.55 0.00 0.29
Financial Leverage Ratio
 2.49 3.52 3.12 2.05 1.91
Debt Service Coverage Ratio
 1.61 0.31 -0.32 -0.10 -6.28
Interest Coverage Ratio
 6.14 0.02 -1.30 0.00 0.00
Debt to Market Cap
 0.02 0.07 0.09 0.05 0.09
Interest Debt Per Share
 1.14 1.33 1.24 0.21 0.26
Net Debt to EBITDA
 0.12 1.19 -22.92 54.93 1.51
Profitability Margins
Gross Profit Margin
57.87%53.46%60.01%66.56%67.38%
EBIT Margin
14.59%0.28%-4.62%-3.77%-38.87%
EBITDA Margin
17.58%5.34%-1.68%-0.92%-30.52%
Operating Profit Margin
15.44%0.09%-6.66%-3.77%-38.87%
Pretax Profit Margin
12.08%-5.70%-9.76%-2.18%-42.45%
Net Profit Margin
12.02%-5.75%-9.80%-2.96%-42.45%
Continuous Operations Profit Margin
12.02%-5.75%-9.80%-2.96%-42.45%
Net Income Per EBT
99.51%100.94%100.39%135.85%100.00%
EBT Per EBIT
78.18%-6330.56%146.63%57.80%109.21%
Return on Assets (ROA)
10.96%-4.99%-5.02%-2.95%-36.04%
Return on Equity (ROE)
40.13%-17.59%-15.65%-6.05%-68.98%
Return on Capital Employed (ROCE)
23.07%0.13%-4.62%-7.69%-44.48%
Return on Invested Capital (ROIC)
20.41%0.12%-4.62%-5.71%-42.14%
Return on Tangible Assets
18.09%-7.51%-9.27%-3.47%-44.49%
Earnings Yield
0.89%-1.01%-1.11%-0.83%-12.72%
Efficiency Ratios
Receivables Turnover
 4.24 6.80 7.28 9.28 11.47
Payables Turnover
 3.09 3.39 3.74 5.73 3.93
Inventory Turnover
 4.39 2.41 1.02 11.61 12.45
Fixed Asset Turnover
 72.03 125.71 186.66 210.95 81.73
Asset Turnover
 0.91 0.87 0.51 1.00 0.85
Working Capital Turnover Ratio
 6.49 3.70 2.46 2.62 1.30
Cash Conversion Cycle
 51.06 97.26 309.05 7.02 -31.84
Days of Sales Outstanding
 86.02 53.67 50.16 39.35 31.81
Days of Inventory Outstanding
 83.21 151.25 356.39 31.43 29.32
Days of Payables Outstanding
 118.17 107.67 97.50 63.75 92.97
Operating Cycle
 169.23 204.92 406.55 70.77 61.13
Cash Flow Ratios
Operating Cash Flow Per Share
 0.55 0.39 0.04 0.27 0.19
Free Cash Flow Per Share
 0.53 0.38 0.04 0.24 0.08
CapEx Per Share
 0.01 0.01 <0.01 0.03 0.11
Free Cash Flow to Operating Cash Flow
 0.97 0.97 0.97 0.89 0.42
Dividend Paid and CapEx Coverage Ratio
 37.56 31.60 37.27 8.79 1.73
Capital Expenditure Coverage Ratio
 37.56 31.60 37.27 8.79 1.73
Operating Cash Flow Coverage Ratio
 0.52 0.34 0.03 1.26 0.74
Operating Cash Flow to Sales Ratio
 0.14 0.13 0.02 0.22 0.23
Free Cash Flow Yield
1.04%2.24%0.27%5.38%2.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 110.73 -99.47 -88.80 -120.01 -7.86
Price-to-Sales (P/S) Ratio
 13.36 5.69 8.84 3.55 3.34
Price-to-Book (P/B) Ratio
 30.55 17.40 14.12 7.26 5.42
Price-to-Free Cash Flow (P/FCF) Ratio
 95.74 44.65 365.77 18.60 34.88
Price-to-Operating Cash Flow Ratio
 94.04 43.24 355.96 16.48 14.71
Price-to-Earnings Growth (PEG) Ratio
 0.15 -7.46 -0.29 1.34 -0.02
Price-to-Fair Value
 30.55 17.40 14.12 7.26 5.42
Enterprise Value Multiple
 76.09 107.83 -547.91 -331.06 -9.42
Enterprise Value
 1.41B 460.09M 359.98M 96.34M 61.13M
EV to EBITDA
 76.09 107.83 -547.91 -331.06 -9.42
EV to Sales
 13.38 5.75 9.23 3.04 2.88
EV to Free Cash Flow
 95.88 45.15 381.74 15.95 30.07
EV to Operating Cash Flow
 93.33 43.72 371.50 14.14 12.68
Tangible Book Value Per Share
 0.03 -0.18 -0.40 0.42 0.33
Shareholders’ Equity Per Share
 1.69 0.97 0.94 0.60 0.52
Tax and Other Ratios
Effective Tax Rate
 <0.01 >-0.01 >-0.01 -0.36 0.00
Revenue Per Share
 3.82 2.97 1.51 1.23 0.85
Net Income Per Share
 0.46 -0.17 -0.15 -0.04 -0.36
Tax Burden
 1.00 1.01 1.00 1.36 1.00
Interest Burden
 0.83 -20.44 2.11 0.58 1.09
Research & Development to Revenue
 0.05 0.10 0.08 0.10 0.19
SG&A to Revenue
 0.37 0.45 0.58 0.60 0.87
Stock-Based Compensation to Revenue
 0.05 0.07 0.08 0.10 0.20
Income Quality
 1.19 -2.29 -0.25 -7.28 -0.53
Currency in USD